🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy and tolerability of th...
Status
Completed
Location
Vienna General Hospital
Start Date
2014-10
Trial ID
NCT02231762
Treatments Being Tested
The purpose of the protocol is to evaluate the correlation between plasma l...
Status
Withdrawn
Location
Centro Médico Nacional Siglo XXI, IMSS
Start Date
2008-05
Trial ID
NCT00517491
Treatments Being Tested
The primary purpose of this extension study was to assess the long term saf...
Status
Completed
Location
Cedars-Sinai Outpatient Cancer Center
Start Date
2009-02
Trial ID
NCT00842348
Treatments Being Tested
This study aims to explore the efficacy and safety of lanreotide Autogel® 1...
Status
Completed
Location
Erasme Hospital
Start Date
2015-12-15
Trial ID
NCT02651987
Treatments Being Tested
The main aim of this study is to assess the efficacy of the co-administrati...
Status
Completed
Location
University Hospital, Charles University
Start Date
2006-10
Trial ID
NCT00383708
Treatments Being Tested
The purpose of the study is to assess the efficacy of an extended injection...
Status
Completed
Location
Universidade Federal do Rio de Janeiro - Department of Internal Medicine - Section of Endocrinology - Neuroendocrine Research Center
Start Date
2008-10
Trial ID
NCT00701363
Treatments Being Tested
The primary objective of the study is to evaluate the impact on quality of ...
Status
Terminated
Location
Ospedale Sacro Cuore di Gesù, U.O.C. Oncologia Medica
Start Date
2015-01
Trial ID
NCT02365584
Treatments Being Tested
Circulating tumour cells (CTCs) are detectable in the blood in around 50% o...
Status
Completed
Location
Basingstoke & North Hampshire Hospital
Start Date
2014-05
Trial ID
NCT02075606
Treatments Being Tested
The hepatocellular carcinoma (HCC) represents more than 5% of all human mal...
Status
Completed
Location
D. Cotugno Hospital
Start Date
2007-04
Trial ID
NCT00495846
Treatments Being Tested
The main aim of this study is to assess the Progression-Free Survival (PFS)...
Status
Withdrawn
Location
Uniwersyteckie Centrum Kliniczne
Start Date
2019-08
Trial ID
NCT03895463